Most SEO work means tab-switching between GSC, GA4, Ads, and AI tools. What if one setup could cross-reference them all?

Comprehensive Python API for Google NotebookLM. Full programmatic access to NotebookLM's features—including capabilities the web UI doesn't expose—from Python or the command line. 📚 Research ...

These metrics should be used as conversation starters and indicators, not as absolute measures of performance. They are most valuable when: Used to identify trends over time Combined with qualitative ...

As Bitcoin's price slump continues to rattle equity-linked crypto firms, Strategy Inc. (previously known as Microstrategy) is pivoting its capital-raising playbook to preferred stock issuance in a bid ...

Strategy (Nasdaq: MSTR), formerly MicroStrategy, reported the financial results for the fourth quarter of 2025 on Feb. 5. The world's largest Bitcoin (BTC) treasury company posted a net loss of $12.4 ...

MicroStrategy says a 90% Bitcoin crash to $8,000 would strain its debt-backed treasury model. Executives stress restructuring or financing would precede forced Bitcoin sales in extreme downturns.

Bitcoin’s drop to $60,000 pushed MicroStrategy’s holdings further below cost, intensifying balance-sheet pressure. The company now trades below asset value, limiting its ability to raise capital ...

Fri, February 6, 2026 at 4:10 PM UTC After adopting fair value accounting for crypto assets in Q1 2025, MSTR reported a $17.44 billion unrealized loss on digital assets in Q4 2025. This drove EPS to ...

MicroStrategy (MSTR) stock crashed 67% over the past year as Bitcoin dropped 17% to $72,725. MicroStrategy holds 640,808 Bitcoin below its $74,032 cost basis with $24.3B in implied unrealized losses.

The FTC first sued Express Scripts, CVS Caremark, and Optum in 2024, claiming anticompetitive and unfair rebating practices surrounding insulin. “Caremark, [Express Scripts], and Optum—as medication ...

The Federal Trade Commission has reached a landmark settlement with Express Scripts, one of the nation’s largest pharmacy benefit managers, requiring sweeping changes aimed at lowering insulin costs ...